Tenaya Therapeutics (TNYA) News Today → We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (From Paradigm Press) (Ad) Free TNYA Stock Alerts $3.64 -0.03 (-0.82%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 2, 2024 | americanbankingnews.comTenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Buy" by AnalystsJune 1, 2024 | americanbankingnews.comFY2024 EPS Estimates for Tenaya Therapeutics, Inc. Lowered by Chardan Capital (NASDAQ:TNYA)May 31, 2024 | marketbeat.comChardan Capital Comments on Tenaya Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:TNYA)Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) - Investment analysts at Chardan Capital dropped their FY2024 earnings estimates for shares of Tenaya Therapeutics in a report released on Tuesday, May 28th. Chardan Capital analyst Y. Livshits now anticipates that the company will earn ($1.61May 30, 2024 | americanbankingnews.comChardan Capital Comments on Tenaya Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:TNYA)May 25, 2024 | finance.yahoo.comWe're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn RateMay 16, 2024 | marketbeat.comCanaccord Genuity Group Trims Tenaya Therapeutics (NASDAQ:TNYA) Target Price to $16.00Canaccord Genuity Group lowered their price objective on shares of Tenaya Therapeutics from $18.00 to $16.00 and set a "buy" rating for the company in a research note on Thursday.May 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Tenaya Therapeutics on Strong Program Prospects and Financial StabilityMay 15, 2024 | marketbeat.comTenaya Therapeutics (NASDAQ:TNYA) Stock Rating Reaffirmed by HC WainwrightHC Wainwright restated a "buy" rating and set a $18.00 price target on shares of Tenaya Therapeutics in a research note on Wednesday.May 15, 2024 | investorplace.comTNYA Stock Earnings: Tenaya Therapeutics Beats EPS for Q1 2024May 14, 2024 | marketwatch.comTenaya Therapeutics Cutting Workforce by 22%May 14, 2024 | globenewswire.comTenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 2, 2024 | globenewswire.comTenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual MeetingApril 14, 2024 | finance.yahoo.comInstitutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the companyApril 13, 2024 | marketbeat.comShort Interest in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Increases By 21.2%Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,090,000 shares, a growth of 21.2% from the March 15th total of 2,550,000 shares. Based on an average trading volume of 609,900 shares, the days-to-cover ratio is currently 5.1 days. Currently, 5.0% of the company's shares are sold short.April 5, 2024 | markets.businessinsider.comTenaya Therapeutics’ Strategic Advantages in Cardiovascular Genetic Medicine Garner Buy RatingMarch 29, 2024 | markets.businessinsider.comOptimistic Buy Rating for Tenaya Therapeutics Based on Promising Gene Therapy Pipeline and Upcoming Clinical MilestonesMarch 26, 2024 | finance.yahoo.com20 Countries with the Highest Heart Disease Deaths Per CapitaMarch 21, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)March 21, 2024 | marketbeat.comTenaya Therapeutics (NASDAQ:TNYA) Stock Rating Reaffirmed by Chardan CapitalChardan Capital reissued a "buy" rating and set a $20.00 target price on shares of Tenaya Therapeutics in a report on Thursday.March 21, 2024 | marketbeat.comLeerink Partnrs Brokers Increase Earnings Estimates for Tenaya Therapeutics, Inc. (NASDAQ:TNYA)Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) - Investment analysts at Leerink Partnrs boosted their Q1 2024 earnings per share (EPS) estimates for Tenaya Therapeutics in a report released on Tuesday, March 19th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will poMarch 21, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Sera Prognostics (SERA), Tenaya Therapeutics (TNYA)March 21, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sera Prognostics (SERA)March 20, 2024 | finance.yahoo.comTenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial ResultsMarch 20, 2024 | marketbeat.comTenaya Therapeutics (NASDAQ:TNYA) Given New $18.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group reduced their price objective on shares of Tenaya Therapeutics from $19.00 to $18.00 and set a "buy" rating on the stock in a research note on Wednesday.March 19, 2024 | markets.businessinsider.comBuy Rating Justified by Tenaya Therapeutics’ Strong Financials and Promising Cardiovascular Pipeline ProgressMarch 19, 2024 | finanznachrichten.deTenaya Therapeutics, Inc.: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 19, 2024 | marketbeat.comTenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Recommendation of "Buy" from AnalystsShares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have earned a consensus rating of "Buy" from the seven brokerages that are currently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1 year prMarch 19, 2024 | marketbeat.comTenaya Therapeutics' (TNYA) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $18.00 price objective on shares of Tenaya Therapeutics in a research report on Tuesday.March 18, 2024 | investorplace.comTNYA Stock Earnings: Tenaya Therapeutics Beats EPS for Q4 2023March 18, 2024 | globenewswire.comTenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 18, 2024 | globenewswire.comTenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications MedicineMarch 16, 2024 | insidertrades.comTimothy Hoey Sells 3,300 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) StockMarch 11, 2024 | marketbeat.comGSA Capital Partners LLP Buys 240,082 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA)GSA Capital Partners LLP grew its stake in shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) by 194.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 363,493 shares of the company's stock aftMarch 8, 2024 | marketbeat.comFmr LLC Sells 567,488 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA)Fmr LLC lowered its holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) by 15.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,186,751 shares of the company's stock after selling 567,488 shares during theFebruary 27, 2024 | globenewswire.comTenaya Therapeutics to Participate in Upcoming March Investor ConferencesFebruary 26, 2024 | globenewswire.comTenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature CommunicationsFebruary 24, 2024 | marketbeat.comTenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares Acquired by Barclays PLCBarclays PLC increased its position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) by 2,635.8% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 249,558 shares of the company's stock after purchasing an additional 240,436 shares during the period. BarclaFebruary 18, 2024 | 247wallst.comInsider Buying: Taking a Controlling Stake in a Struggling Retailer?February 16, 2024 | finance.yahoo.comTNYA Mar 2024 7.500 putFebruary 16, 2024 | finance.yahoo.comTNYA Apr 2024 7.500 putFebruary 13, 2024 | marketbeat.comTenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Buy" from BrokeragesTenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) has been given a consensus recommendation of "Buy" by the seven analysts that are currently covering the company, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month priFebruary 9, 2024 | msn.comTenaya Therapeutics Announces Speculative Offering OutlookFebruary 9, 2024 | finance.yahoo.comWall Street Analysts Think Tenaya Therapeutics, Inc. (TNYA) Could Surge 273.1%: Read This Before Placing a BetFebruary 9, 2024 | msn.comTenaya Therapeutics Secures $50 Million in Share SaleFebruary 8, 2024 | markets.businessinsider.comTenaya Announces Pricing Of $50 Mln Underwritten Offering; Stock UpFebruary 8, 2024 | finance.yahoo.comTenaya Therapeutics Announces Pricing of Underwritten OfferingFebruary 6, 2024 | msn.com5 Russell 2000 Stocks Poised to Give the Large Caps a Run for Their MoneyJanuary 26, 2024 | finance.yahoo.comTenaya Therapeutics, Inc. (TNYA) Upgraded to Strong Buy: Here's WhyJanuary 26, 2024 | seekingalpha.comDBX, CMPS and EWBC are among after hour moversJanuary 22, 2024 | marketbeat.comAnalysts Offer Predictions for Tenaya Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:TNYA)Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) - Investment analysts at Leerink Partnrs boosted their FY2023 earnings per share estimates for shares of Tenaya Therapeutics in a note issued to investors on Wednesday, January 17th. Leerink Partnrs analyst M. Foroohar now forecasts that the c Get Tenaya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Secret energy grid to power millions of homes (Ad)This high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type of energy system the world has never seen before. Click here to get all the details. TNYA Media Mentions By Week TNYA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNYA News Sentiment▼-0.070.72▲Average Medical News Sentiment TNYA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNYA Articles This Week▼21▲TNYA Articles Average Week Get Tenaya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Precigen News Today Adaptimmune Therapeutics News Today Absci News Today BioAtla News Today ORIC Pharmaceuticals News Today LianBio News Today VBI Vaccines News Today Tarsus Pharmaceuticals News Today 4D Molecular Therapeutics News Today Ginkgo Bioworks News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNYA) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersSecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type ...Porter & Company | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | Sponsored